nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—ADRB1—stomach cancer	0.489	0.543	CbGaD
Levobunolol—ADRB2—stomach cancer	0.411	0.457	CbGaD
Levobunolol—Stinging—Mitomycin—stomach cancer	0.00298	0.0329	CcSEcCtD
Levobunolol—Lethargy—Floxuridine—stomach cancer	0.00228	0.0252	CcSEcCtD
Levobunolol—Cardiac failure congestive—Mitomycin—stomach cancer	0.00193	0.0213	CcSEcCtD
Levobunolol—Rash generalised—Docetaxel—stomach cancer	0.0017	0.0188	CcSEcCtD
Levobunolol—Diabetic—Methotrexate—stomach cancer	0.00156	0.0173	CcSEcCtD
Levobunolol—Alopecia—Floxuridine—stomach cancer	0.00136	0.0151	CcSEcCtD
Levobunolol—Stinging—Fluorouracil—stomach cancer	0.00124	0.0137	CcSEcCtD
Levobunolol—Confusional state—Floxuridine—stomach cancer	0.00111	0.0122	CcSEcCtD
Levobunolol—Keratitis—Capecitabine—stomach cancer	0.00108	0.0119	CcSEcCtD
Levobunolol—Alopecia—Mitomycin—stomach cancer	0.00107	0.0118	CcSEcCtD
Levobunolol—Syncope—Mitomycin—stomach cancer	0.000945	0.0105	CcSEcCtD
Levobunolol—Loss of consciousness—Mitomycin—stomach cancer	0.000926	0.0102	CcSEcCtD
Levobunolol—Feeling abnormal—Floxuridine—stomach cancer	0.000903	0.00999	CcSEcCtD
Levobunolol—Confusional state—Mitomycin—stomach cancer	0.000867	0.00959	CcSEcCtD
Levobunolol—Shock—Mitomycin—stomach cancer	0.000846	0.00936	CcSEcCtD
Levobunolol—Hypersensitivity—Floxuridine—stomach cancer	0.000807	0.00893	CcSEcCtD
Levobunolol—Visual disturbance—Irinotecan—stomach cancer	0.000802	0.00887	CcSEcCtD
Levobunolol—Asthenia—Floxuridine—stomach cancer	0.000786	0.0087	CcSEcCtD
Levobunolol—Cerebrovascular accident—Irinotecan—stomach cancer	0.000775	0.00858	CcSEcCtD
Levobunolol—Dyspnoea—Mitomycin—stomach cancer	0.000767	0.00848	CcSEcCtD
Levobunolol—Keratitis—Epirubicin—stomach cancer	0.000753	0.00832	CcSEcCtD
Levobunolol—Diarrhoea—Floxuridine—stomach cancer	0.00075	0.00829	CcSEcCtD
Levobunolol—Lethargy—Fluorouracil—stomach cancer	0.000743	0.00821	CcSEcCtD
Levobunolol—Timolol—ADRB1—stomach cancer	0.000741	0.0858	CrCbGaD
Levobunolol—Respiratory failure—Docetaxel—stomach cancer	0.000737	0.00815	CcSEcCtD
Levobunolol—Pain—Mitomycin—stomach cancer	0.000735	0.00813	CcSEcCtD
Levobunolol—Cardiac arrest—Irinotecan—stomach cancer	0.000723	0.00799	CcSEcCtD
Levobunolol—Feeling abnormal—Mitomycin—stomach cancer	0.000709	0.00784	CcSEcCtD
Levobunolol—Keratitis—Doxorubicin—stomach cancer	0.000696	0.0077	CcSEcCtD
Levobunolol—Cardiac arrest—Fluorouracil—stomach cancer	0.000692	0.00765	CcSEcCtD
Levobunolol—Headache—Floxuridine—stomach cancer	0.000687	0.00759	CcSEcCtD
Levobunolol—Ataxia—Fluorouracil—stomach cancer	0.000684	0.00757	CcSEcCtD
Levobunolol—Carteolol—ADRB1—stomach cancer	0.000661	0.0765	CrCbGaD
Levobunolol—Nausea—Floxuridine—stomach cancer	0.000651	0.0072	CcSEcCtD
Levobunolol—Timolol—ADRB2—stomach cancer	0.000623	0.0721	CrCbGaD
Levobunolol—Asthenia—Mitomycin—stomach cancer	0.000617	0.00682	CcSEcCtD
Levobunolol—Stinging—Epirubicin—stomach cancer	0.000602	0.00666	CcSEcCtD
Levobunolol—Nadolol—ADRB1—stomach cancer	0.000589	0.0681	CrCbGaD
Levobunolol—Diarrhoea—Mitomycin—stomach cancer	0.000588	0.00651	CcSEcCtD
Levobunolol—Diabetes mellitus—Capecitabine—stomach cancer	0.000585	0.00647	CcSEcCtD
Levobunolol—Cardiac failure congestive—Docetaxel—stomach cancer	0.000579	0.00641	CcSEcCtD
Levobunolol—Dizziness—Mitomycin—stomach cancer	0.000569	0.00629	CcSEcCtD
Levobunolol—Bupranolol—ADRB1—stomach cancer	0.000562	0.065	CrCbGaD
Levobunolol—Stinging—Doxorubicin—stomach cancer	0.000557	0.00617	CcSEcCtD
Levobunolol—Carteolol—ADRB2—stomach cancer	0.000556	0.0643	CrCbGaD
Levobunolol—Visual disturbance—Docetaxel—stomach cancer	0.000554	0.00613	CcSEcCtD
Levobunolol—Conjunctivitis—Fluorouracil—stomach cancer	0.000545	0.00603	CcSEcCtD
Levobunolol—Headache—Mitomycin—stomach cancer	0.000539	0.00596	CcSEcCtD
Levobunolol—Lethargy—Docetaxel—stomach cancer	0.000536	0.00593	CcSEcCtD
Levobunolol—Bradycardia—Irinotecan—stomach cancer	0.000535	0.00592	CcSEcCtD
Levobunolol—Respiratory failure—Methotrexate—stomach cancer	0.000531	0.00587	CcSEcCtD
Levobunolol—Salbutamol—ADRB1—stomach cancer	0.000528	0.0611	CrCbGaD
Levobunolol—Lethargy—Capecitabine—stomach cancer	0.000519	0.00574	CcSEcCtD
Levobunolol—Cerebrovascular accident—Capecitabine—stomach cancer	0.000519	0.00574	CcSEcCtD
Levobunolol—Penbutolol—ADRB1—stomach cancer	0.000514	0.0595	CrCbGaD
Levobunolol—Nausea—Mitomycin—stomach cancer	0.000511	0.00565	CcSEcCtD
Levobunolol—Diplopia—Capecitabine—stomach cancer	0.000509	0.00563	CcSEcCtD
Levobunolol—Visual impairment—Irinotecan—stomach cancer	0.000507	0.0056	CcSEcCtD
Levobunolol—Atrioventricular block—Epirubicin—stomach cancer	0.000503	0.00557	CcSEcCtD
Levobunolol—Nadolol—ADRB2—stomach cancer	0.000495	0.0573	CrCbGaD
Levobunolol—Ataxia—Docetaxel—stomach cancer	0.000494	0.00546	CcSEcCtD
Levobunolol—Cardiac arrest—Capecitabine—stomach cancer	0.000484	0.00535	CcSEcCtD
Levobunolol—Ataxia—Capecitabine—stomach cancer	0.000478	0.00529	CcSEcCtD
Levobunolol—Bupranolol—ADRB2—stomach cancer	0.000472	0.0547	CrCbGaD
Levobunolol—Arrhythmia—Irinotecan—stomach cancer	0.00047	0.00519	CcSEcCtD
Levobunolol—Atrioventricular block—Doxorubicin—stomach cancer	0.000466	0.00515	CcSEcCtD
Levobunolol—Alopecia—Irinotecan—stomach cancer	0.000465	0.00514	CcSEcCtD
Levobunolol—Penbutolol—HTR1A—stomach cancer	0.00046	0.0532	CrCbGaD
Levobunolol—Arrhythmia—Fluorouracil—stomach cancer	0.00045	0.00497	CcSEcCtD
Levobunolol—Bronchospasm—Docetaxel—stomach cancer	0.000447	0.00494	CcSEcCtD
Levobunolol—Alopecia—Fluorouracil—stomach cancer	0.000445	0.00492	CcSEcCtD
Levobunolol—Salbutamol—ADRB2—stomach cancer	0.000444	0.0514	CrCbGaD
Levobunolol—Diabetes mellitus—Methotrexate—stomach cancer	0.000435	0.00481	CcSEcCtD
Levobunolol—Bronchospasm—Capecitabine—stomach cancer	0.000432	0.00478	CcSEcCtD
Levobunolol—Penbutolol—ADRB2—stomach cancer	0.000432	0.05	CrCbGaD
Levobunolol—Syncope—Irinotecan—stomach cancer	0.00041	0.00454	CcSEcCtD
Levobunolol—Diabetes mellitus—Epirubicin—stomach cancer	0.000407	0.00451	CcSEcCtD
Levobunolol—Loss of consciousness—Irinotecan—stomach cancer	0.000402	0.00445	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.000401	0.00444	CcSEcCtD
Levobunolol—Visual disturbance—Methotrexate—stomach cancer	0.0004	0.00442	CcSEcCtD
Levobunolol—Conjunctivitis—Docetaxel—stomach cancer	0.000393	0.00435	CcSEcCtD
Levobunolol—Depression—Capecitabine—stomach cancer	0.000391	0.00432	CcSEcCtD
Levobunolol—Cardiac failure congestive—Epirubicin—stomach cancer	0.000391	0.00432	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.000389	0.0043	CcSEcCtD
Levobunolol—Lethargy—Methotrexate—stomach cancer	0.000386	0.00427	CcSEcCtD
Levobunolol—Cerebrovascular accident—Methotrexate—stomach cancer	0.000386	0.00427	CcSEcCtD
Levobunolol—Conjunctivitis—Capecitabine—stomach cancer	0.000381	0.00421	CcSEcCtD
Levobunolol—Diabetes mellitus—Doxorubicin—stomach cancer	0.000377	0.00417	CcSEcCtD
Levobunolol—Confusional state—Irinotecan—stomach cancer	0.000377	0.00417	CcSEcCtD
Levobunolol—Chest pain—Fluorouracil—stomach cancer	0.000373	0.00413	CcSEcCtD
Levobunolol—Pindolol—ADRB1—stomach cancer	0.00037	0.0429	CrCbGaD
Levobunolol—Shock—Irinotecan—stomach cancer	0.000367	0.00406	CcSEcCtD
Levobunolol—Hypoglycaemia—Epirubicin—stomach cancer	0.000363	0.00402	CcSEcCtD
Levobunolol—Lethargy—Epirubicin—stomach cancer	0.000362	0.004	CcSEcCtD
Levobunolol—Cerebrovascular accident—Epirubicin—stomach cancer	0.000362	0.004	CcSEcCtD
Levobunolol—Cardiac failure congestive—Doxorubicin—stomach cancer	0.000362	0.004	CcSEcCtD
Levobunolol—Confusional state—Fluorouracil—stomach cancer	0.000361	0.00399	CcSEcCtD
Levobunolol—Bradycardia—Capecitabine—stomach cancer	0.000358	0.00396	CcSEcCtD
Levobunolol—Ataxia—Methotrexate—stomach cancer	0.000356	0.00394	CcSEcCtD
Levobunolol—Diplopia—Epirubicin—stomach cancer	0.000354	0.00392	CcSEcCtD
Levobunolol—Visual impairment—Docetaxel—stomach cancer	0.00035	0.00387	CcSEcCtD
Levobunolol—Hypotension—Irinotecan—stomach cancer	0.000349	0.00386	CcSEcCtD
Levobunolol—Erythema multiforme—Docetaxel—stomach cancer	0.000344	0.0038	CcSEcCtD
Levobunolol—Visual impairment—Capecitabine—stomach cancer	0.000339	0.00375	CcSEcCtD
Levobunolol—Cardiac arrest—Epirubicin—stomach cancer	0.000337	0.00373	CcSEcCtD
Levobunolol—Hypoglycaemia—Doxorubicin—stomach cancer	0.000336	0.00372	CcSEcCtD
Levobunolol—Paraesthesia—Irinotecan—stomach cancer	0.000335	0.00371	CcSEcCtD
Levobunolol—Lethargy—Doxorubicin—stomach cancer	0.000335	0.0037	CcSEcCtD
Levobunolol—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000335	0.0037	CcSEcCtD
Levobunolol—Hypotension—Fluorouracil—stomach cancer	0.000334	0.0037	CcSEcCtD
Levobunolol—Ataxia—Epirubicin—stomach cancer	0.000333	0.00368	CcSEcCtD
Levobunolol—Dyspnoea—Irinotecan—stomach cancer	0.000333	0.00368	CcSEcCtD
Levobunolol—Erythema multiforme—Capecitabine—stomach cancer	0.000333	0.00368	CcSEcCtD
Levobunolol—Pindolol—HTR1A—stomach cancer	0.000331	0.0383	CrCbGaD
Levobunolol—Diplopia—Doxorubicin—stomach cancer	0.000328	0.00363	CcSEcCtD
Levobunolol—Arrhythmia—Docetaxel—stomach cancer	0.000325	0.00359	CcSEcCtD
Levobunolol—Paraesthesia—Fluorouracil—stomach cancer	0.000321	0.00355	CcSEcCtD
Levobunolol—Alopecia—Docetaxel—stomach cancer	0.000321	0.00355	CcSEcCtD
Levobunolol—Pain—Irinotecan—stomach cancer	0.000319	0.00353	CcSEcCtD
Levobunolol—Dyspnoea—Fluorouracil—stomach cancer	0.000319	0.00353	CcSEcCtD
Levobunolol—Arrhythmia—Capecitabine—stomach cancer	0.000314	0.00348	CcSEcCtD
Levobunolol—Cardiac arrest—Doxorubicin—stomach cancer	0.000312	0.00345	CcSEcCtD
Levobunolol—Pindolol—ADRB2—stomach cancer	0.000311	0.036	CrCbGaD
Levobunolol—Alopecia—Capecitabine—stomach cancer	0.000311	0.00344	CcSEcCtD
Levobunolol—Ataxia—Doxorubicin—stomach cancer	0.000308	0.00341	CcSEcCtD
Levobunolol—Feeling abnormal—Irinotecan—stomach cancer	0.000308	0.0034	CcSEcCtD
Levobunolol—Pain—Fluorouracil—stomach cancer	0.000306	0.00338	CcSEcCtD
Levobunolol—Erectile dysfunction—Methotrexate—stomach cancer	0.000301	0.00333	CcSEcCtD
Levobunolol—Feeling abnormal—Fluorouracil—stomach cancer	0.000295	0.00326	CcSEcCtD
Levobunolol—Depression—Methotrexate—stomach cancer	0.000291	0.00322	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000289	0.0032	CcSEcCtD
Levobunolol—Urticaria—Fluorouracil—stomach cancer	0.000284	0.00314	CcSEcCtD
Levobunolol—Syncope—Docetaxel—stomach cancer	0.000284	0.00314	CcSEcCtD
Levobunolol—Conjunctivitis—Methotrexate—stomach cancer	0.000284	0.00314	CcSEcCtD
Levobunolol—Palpitations—Docetaxel—stomach cancer	0.00028	0.00309	CcSEcCtD
Levobunolol—Loss of consciousness—Docetaxel—stomach cancer	0.000278	0.00308	CcSEcCtD
Levobunolol—Hypersensitivity—Irinotecan—stomach cancer	0.000275	0.00304	CcSEcCtD
Levobunolol—Syncope—Capecitabine—stomach cancer	0.000275	0.00304	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000271	0.00299	CcSEcCtD
Levobunolol—Palpitations—Capecitabine—stomach cancer	0.000271	0.00299	CcSEcCtD
Levobunolol—Chest pain—Docetaxel—stomach cancer	0.000269	0.00298	CcSEcCtD
Levobunolol—Loss of consciousness—Capecitabine—stomach cancer	0.000269	0.00298	CcSEcCtD
Levobunolol—Asthenia—Irinotecan—stomach cancer	0.000268	0.00296	CcSEcCtD
Levobunolol—Conjunctivitis—Epirubicin—stomach cancer	0.000265	0.00294	CcSEcCtD
Levobunolol—Hypersensitivity—Fluorouracil—stomach cancer	0.000264	0.00291	CcSEcCtD
Levobunolol—Chest pain—Capecitabine—stomach cancer	0.000261	0.00288	CcSEcCtD
Levobunolol—Confusional state—Docetaxel—stomach cancer	0.00026	0.00288	CcSEcCtD
Levobunolol—Diarrhoea—Irinotecan—stomach cancer	0.000256	0.00283	CcSEcCtD
Levobunolol—Shock—Docetaxel—stomach cancer	0.000254	0.00281	CcSEcCtD
Levobunolol—Pruritus—Fluorouracil—stomach cancer	0.000253	0.0028	CcSEcCtD
Levobunolol—Visual impairment—Methotrexate—stomach cancer	0.000252	0.00279	CcSEcCtD
Levobunolol—Confusional state—Capecitabine—stomach cancer	0.000252	0.00279	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00025	0.00277	CcSEcCtD
Levobunolol—Bradycardia—Epirubicin—stomach cancer	0.00025	0.00276	CcSEcCtD
Levobunolol—Erythema multiforme—Methotrexate—stomach cancer	0.000248	0.00274	CcSEcCtD
Levobunolol—Dizziness—Irinotecan—stomach cancer	0.000247	0.00273	CcSEcCtD
Levobunolol—Shock—Capecitabine—stomach cancer	0.000246	0.00272	CcSEcCtD
Levobunolol—Conjunctivitis—Doxorubicin—stomach cancer	0.000246	0.00272	CcSEcCtD
Levobunolol—Diarrhoea—Fluorouracil—stomach cancer	0.000245	0.00271	CcSEcCtD
Levobunolol—Hypotension—Docetaxel—stomach cancer	0.000241	0.00267	CcSEcCtD
Levobunolol—Dizziness—Fluorouracil—stomach cancer	0.000237	0.00262	CcSEcCtD
Levobunolol—Visual impairment—Epirubicin—stomach cancer	0.000236	0.00261	CcSEcCtD
Levobunolol—Headache—Irinotecan—stomach cancer	0.000234	0.00259	CcSEcCtD
Levobunolol—Hypotension—Capecitabine—stomach cancer	0.000234	0.00258	CcSEcCtD
Levobunolol—Paraesthesia—Docetaxel—stomach cancer	0.000232	0.00256	CcSEcCtD
Levobunolol—Erythema multiforme—Epirubicin—stomach cancer	0.000232	0.00256	CcSEcCtD
Levobunolol—Alopecia—Methotrexate—stomach cancer	0.000231	0.00256	CcSEcCtD
Levobunolol—Bradycardia—Doxorubicin—stomach cancer	0.000231	0.00255	CcSEcCtD
Levobunolol—Dyspnoea—Docetaxel—stomach cancer	0.00023	0.00255	CcSEcCtD
Levobunolol—Paraesthesia—Capecitabine—stomach cancer	0.000224	0.00248	CcSEcCtD
Levobunolol—Headache—Fluorouracil—stomach cancer	0.000224	0.00248	CcSEcCtD
Levobunolol—Dyspnoea—Capecitabine—stomach cancer	0.000223	0.00246	CcSEcCtD
Levobunolol—Nausea—Irinotecan—stomach cancer	0.000222	0.00245	CcSEcCtD
Levobunolol—Pain—Docetaxel—stomach cancer	0.000221	0.00244	CcSEcCtD
Levobunolol—Arrhythmia—Epirubicin—stomach cancer	0.000219	0.00242	CcSEcCtD
Levobunolol—Visual impairment—Doxorubicin—stomach cancer	0.000219	0.00242	CcSEcCtD
Levobunolol—Alopecia—Epirubicin—stomach cancer	0.000217	0.0024	CcSEcCtD
Levobunolol—Erythema multiforme—Doxorubicin—stomach cancer	0.000214	0.00237	CcSEcCtD
Levobunolol—Pain—Capecitabine—stomach cancer	0.000214	0.00236	CcSEcCtD
Levobunolol—Feeling abnormal—Docetaxel—stomach cancer	0.000213	0.00235	CcSEcCtD
Levobunolol—Nausea—Fluorouracil—stomach cancer	0.000212	0.00235	CcSEcCtD
Levobunolol—Feeling abnormal—Capecitabine—stomach cancer	0.000206	0.00228	CcSEcCtD
Levobunolol—Arrhythmia—Doxorubicin—stomach cancer	0.000203	0.00224	CcSEcCtD
Levobunolol—Propranolol—ADRB1—stomach cancer	0.000202	0.0234	CrCbGaD
Levobunolol—Alopecia—Doxorubicin—stomach cancer	0.0002	0.00222	CcSEcCtD
Levobunolol—Urticaria—Capecitabine—stomach cancer	0.000199	0.0022	CcSEcCtD
Levobunolol—Chest pain—Methotrexate—stomach cancer	0.000194	0.00215	CcSEcCtD
Levobunolol—Syncope—Epirubicin—stomach cancer	0.000191	0.00212	CcSEcCtD
Levobunolol—Hypersensitivity—Docetaxel—stomach cancer	0.00019	0.0021	CcSEcCtD
Levobunolol—Palpitations—Epirubicin—stomach cancer	0.000189	0.00209	CcSEcCtD
Levobunolol—Confusional state—Methotrexate—stomach cancer	0.000188	0.00208	CcSEcCtD
Levobunolol—Loss of consciousness—Epirubicin—stomach cancer	0.000188	0.00207	CcSEcCtD
Levobunolol—Asthenia—Docetaxel—stomach cancer	0.000185	0.00205	CcSEcCtD
Levobunolol—Hypersensitivity—Capecitabine—stomach cancer	0.000184	0.00204	CcSEcCtD
Levobunolol—Pruritus—Docetaxel—stomach cancer	0.000183	0.00202	CcSEcCtD
Levobunolol—Chest pain—Epirubicin—stomach cancer	0.000182	0.00201	CcSEcCtD
Levobunolol—Propranolol—HTR1A—stomach cancer	0.000181	0.0209	CrCbGaD
Levobunolol—Asthenia—Capecitabine—stomach cancer	0.000179	0.00198	CcSEcCtD
Levobunolol—Syncope—Doxorubicin—stomach cancer	0.000177	0.00196	CcSEcCtD
Levobunolol—Pruritus—Capecitabine—stomach cancer	0.000177	0.00196	CcSEcCtD
Levobunolol—Diarrhoea—Docetaxel—stomach cancer	0.000177	0.00195	CcSEcCtD
Levobunolol—Confusional state—Epirubicin—stomach cancer	0.000176	0.00194	CcSEcCtD
Levobunolol—Palpitations—Doxorubicin—stomach cancer	0.000174	0.00193	CcSEcCtD
Levobunolol—Hypotension—Methotrexate—stomach cancer	0.000174	0.00192	CcSEcCtD
Levobunolol—Loss of consciousness—Doxorubicin—stomach cancer	0.000174	0.00192	CcSEcCtD
Levobunolol—Shock—Epirubicin—stomach cancer	0.000171	0.00189	CcSEcCtD
Levobunolol—Diarrhoea—Capecitabine—stomach cancer	0.000171	0.00189	CcSEcCtD
Levobunolol—Dizziness—Docetaxel—stomach cancer	0.000171	0.00189	CcSEcCtD
Levobunolol—Propranolol—ADRB2—stomach cancer	0.00017	0.0197	CrCbGaD
Levobunolol—Chest pain—Doxorubicin—stomach cancer	0.000168	0.00186	CcSEcCtD
Levobunolol—Paraesthesia—Methotrexate—stomach cancer	0.000167	0.00185	CcSEcCtD
Levobunolol—Dyspnoea—Methotrexate—stomach cancer	0.000166	0.00183	CcSEcCtD
Levobunolol—Dizziness—Capecitabine—stomach cancer	0.000165	0.00183	CcSEcCtD
Levobunolol—Hypotension—Epirubicin—stomach cancer	0.000163	0.0018	CcSEcCtD
Levobunolol—Confusional state—Doxorubicin—stomach cancer	0.000162	0.0018	CcSEcCtD
Levobunolol—Headache—Docetaxel—stomach cancer	0.000162	0.00179	CcSEcCtD
Levobunolol—Pain—Methotrexate—stomach cancer	0.000159	0.00176	CcSEcCtD
Levobunolol—Shock—Doxorubicin—stomach cancer	0.000159	0.00175	CcSEcCtD
Levobunolol—Headache—Capecitabine—stomach cancer	0.000157	0.00173	CcSEcCtD
Levobunolol—Paraesthesia—Epirubicin—stomach cancer	0.000156	0.00173	CcSEcCtD
Levobunolol—Dyspnoea—Epirubicin—stomach cancer	0.000155	0.00172	CcSEcCtD
Levobunolol—Nausea—Docetaxel—stomach cancer	0.000153	0.0017	CcSEcCtD
Levobunolol—Feeling abnormal—Methotrexate—stomach cancer	0.000153	0.0017	CcSEcCtD
Levobunolol—Hypotension—Doxorubicin—stomach cancer	0.000151	0.00167	CcSEcCtD
Levobunolol—Pain—Epirubicin—stomach cancer	0.000149	0.00165	CcSEcCtD
Levobunolol—Nausea—Capecitabine—stomach cancer	0.000148	0.00164	CcSEcCtD
Levobunolol—Urticaria—Methotrexate—stomach cancer	0.000148	0.00164	CcSEcCtD
Levobunolol—Paraesthesia—Doxorubicin—stomach cancer	0.000145	0.0016	CcSEcCtD
Levobunolol—Dyspnoea—Doxorubicin—stomach cancer	0.000144	0.00159	CcSEcCtD
Levobunolol—Feeling abnormal—Epirubicin—stomach cancer	0.000144	0.00159	CcSEcCtD
Levobunolol—Urticaria—Epirubicin—stomach cancer	0.000138	0.00153	CcSEcCtD
Levobunolol—Pain—Doxorubicin—stomach cancer	0.000138	0.00152	CcSEcCtD
Levobunolol—Hypersensitivity—Methotrexate—stomach cancer	0.000137	0.00152	CcSEcCtD
Levobunolol—Asthenia—Methotrexate—stomach cancer	0.000134	0.00148	CcSEcCtD
Levobunolol—Feeling abnormal—Doxorubicin—stomach cancer	0.000133	0.00147	CcSEcCtD
Levobunolol—Pruritus—Methotrexate—stomach cancer	0.000132	0.00146	CcSEcCtD
Levobunolol—Hypersensitivity—Epirubicin—stomach cancer	0.000128	0.00142	CcSEcCtD
Levobunolol—Urticaria—Doxorubicin—stomach cancer	0.000128	0.00142	CcSEcCtD
Levobunolol—Diarrhoea—Methotrexate—stomach cancer	0.000127	0.00141	CcSEcCtD
Levobunolol—Asthenia—Epirubicin—stomach cancer	0.000125	0.00138	CcSEcCtD
Levobunolol—Pruritus—Epirubicin—stomach cancer	0.000123	0.00136	CcSEcCtD
Levobunolol—Dizziness—Methotrexate—stomach cancer	0.000123	0.00136	CcSEcCtD
Levobunolol—Diarrhoea—Epirubicin—stomach cancer	0.000119	0.00132	CcSEcCtD
Levobunolol—Hypersensitivity—Doxorubicin—stomach cancer	0.000119	0.00131	CcSEcCtD
Levobunolol—Headache—Methotrexate—stomach cancer	0.000117	0.00129	CcSEcCtD
Levobunolol—Asthenia—Doxorubicin—stomach cancer	0.000116	0.00128	CcSEcCtD
Levobunolol—Dizziness—Epirubicin—stomach cancer	0.000115	0.00127	CcSEcCtD
Levobunolol—Pruritus—Doxorubicin—stomach cancer	0.000114	0.00126	CcSEcCtD
Levobunolol—Nausea—Methotrexate—stomach cancer	0.000111	0.00122	CcSEcCtD
Levobunolol—Diarrhoea—Doxorubicin—stomach cancer	0.00011	0.00122	CcSEcCtD
Levobunolol—Headache—Epirubicin—stomach cancer	0.000109	0.00121	CcSEcCtD
Levobunolol—Dizziness—Doxorubicin—stomach cancer	0.000107	0.00118	CcSEcCtD
Levobunolol—Nausea—Epirubicin—stomach cancer	0.000103	0.00114	CcSEcCtD
Levobunolol—Headache—Doxorubicin—stomach cancer	0.000101	0.00112	CcSEcCtD
Levobunolol—Nausea—Doxorubicin—stomach cancer	9.57e-05	0.00106	CcSEcCtD
Levobunolol—ADRB2—Arf6 signaling events—MET—stomach cancer	9.42e-06	0.0129	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—F2R—stomach cancer	8.54e-06	0.0117	CbGpPWpGaD
Levobunolol—ADRB1—Endothelin Pathways—NOS3—stomach cancer	7.89e-06	0.0108	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS2—stomach cancer	7.85e-06	0.0108	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—KISS1R—stomach cancer	7.82e-06	0.0107	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS2—stomach cancer	7.68e-06	0.0105	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KISS1R—stomach cancer	7.65e-06	0.0105	CbGpPWpGaD
Levobunolol—ADRB2—Arf6 trafficking events—CDH1—stomach cancer	6.45e-06	0.00885	CbGpPWpGaD
Levobunolol—ADRB2—G alpha (s) signalling events—ADRB1—stomach cancer	6.07e-06	0.00833	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—KISS1R—stomach cancer	5.96e-06	0.00818	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—KISS1R—stomach cancer	5.83e-06	0.008	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	5.65e-06	0.00776	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	5.53e-06	0.00759	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—stomach cancer	5.24e-06	0.00719	CbGpPWpGaD
Levobunolol—ADRB1—Endothelin Pathways—MAPK1—stomach cancer	5.12e-06	0.00702	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	5.04e-06	0.00692	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—ADRB2—stomach cancer	5.03e-06	0.0069	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	4.93e-06	0.00677	CbGpPWpGaD
Levobunolol—ADRB2—Arf6 signaling events—EGFR—stomach cancer	4.77e-06	0.00655	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—stomach cancer	4.34e-06	0.00596	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HRH4—stomach cancer	4.31e-06	0.00591	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HRH4—stomach cancer	4.21e-06	0.00578	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—KISS1—stomach cancer	3.84e-06	0.00527	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	3.83e-06	0.00526	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	3.79e-06	0.0052	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—KISS1—stomach cancer	3.75e-06	0.00515	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	3.75e-06	0.00515	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	3.71e-06	0.00509	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	3.69e-06	0.00507	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	3.61e-06	0.00496	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	3.38e-06	0.00464	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—KISS1R—stomach cancer	3.37e-06	0.00462	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—KISS1R—stomach cancer	3.29e-06	0.00452	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	3.28e-06	0.00451	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	3.25e-06	0.00446	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	3.21e-06	0.00441	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	3.18e-06	0.00436	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	3.16e-06	0.00434	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	3.09e-06	0.00425	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—KISS1R—stomach cancer	3.06e-06	0.0042	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	3.05e-06	0.00419	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—KISS1R—stomach cancer	2.99e-06	0.0041	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	2.99e-06	0.0041	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—PRKCB—stomach cancer	2.97e-06	0.00408	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—PRKCB—stomach cancer	2.91e-06	0.00399	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	2.89e-06	0.00397	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	2.8e-06	0.00384	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—AGTR2—stomach cancer	2.5e-06	0.00343	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—F2R—stomach cancer	2.47e-06	0.0034	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—AGTR2—stomach cancer	2.45e-06	0.00336	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HRH4—stomach cancer	2.43e-06	0.00334	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—F2R—stomach cancer	2.42e-06	0.00332	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HTR1A—stomach cancer	2.41e-06	0.00331	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	2.4e-06	0.00329	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HRH4—stomach cancer	2.38e-06	0.00327	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR1A—stomach cancer	2.36e-06	0.00323	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—ANXA1—stomach cancer	2.33e-06	0.00319	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—ANXA1—stomach cancer	2.27e-06	0.00312	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HRH4—stomach cancer	2.21e-06	0.00303	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—ADRB1—stomach cancer	2.2e-06	0.00302	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—KISS1—stomach cancer	2.17e-06	0.00298	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HRH4—stomach cancer	2.16e-06	0.00297	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—KISS1—stomach cancer	2.12e-06	0.00291	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—KISS1—stomach cancer	1.97e-06	0.0027	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—KISS1—stomach cancer	1.93e-06	0.00265	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GAST—stomach cancer	1.87e-06	0.00256	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—RGS2—stomach cancer	1.87e-06	0.00256	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—ADRB2—stomach cancer	1.82e-06	0.0025	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—RGS2—stomach cancer	1.82e-06	0.0025	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GAST—stomach cancer	1.82e-06	0.0025	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KISS1R—stomach cancer	1.81e-06	0.00248	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GLI3—stomach cancer	1.81e-06	0.00248	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KISS1R—stomach cancer	1.77e-06	0.00242	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GLI3—stomach cancer	1.77e-06	0.00242	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RBP1—stomach cancer	1.72e-06	0.00236	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—RGS2—stomach cancer	1.69e-06	0.00233	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GAST—stomach cancer	1.69e-06	0.00233	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RBP1—stomach cancer	1.69e-06	0.00231	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—RGS2—stomach cancer	1.66e-06	0.00227	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GAST—stomach cancer	1.66e-06	0.00227	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AGTR2—stomach cancer	1.41e-06	0.00194	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—WWOX—stomach cancer	1.4e-06	0.00193	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—F2R—stomach cancer	1.4e-06	0.00192	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AGTR2—stomach cancer	1.38e-06	0.0019	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—WWOX—stomach cancer	1.37e-06	0.00189	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—F2R—stomach cancer	1.37e-06	0.00188	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR1A—stomach cancer	1.36e-06	0.00187	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR1A—stomach cancer	1.33e-06	0.00183	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ANXA1—stomach cancer	1.31e-06	0.0018	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HRH4—stomach cancer	1.31e-06	0.00179	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—WIF1—stomach cancer	1.31e-06	0.00179	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ANXA1—stomach cancer	1.29e-06	0.00176	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AGTR2—stomach cancer	1.28e-06	0.00176	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—WIF1—stomach cancer	1.28e-06	0.00175	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HRH4—stomach cancer	1.28e-06	0.00175	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—F2R—stomach cancer	1.27e-06	0.00174	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AGTR2—stomach cancer	1.26e-06	0.00172	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ADRB1—stomach cancer	1.24e-06	0.00171	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—F2R—stomach cancer	1.24e-06	0.0017	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR1A—stomach cancer	1.24e-06	0.0017	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR1A—stomach cancer	1.21e-06	0.00166	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKAB1—stomach cancer	1.2e-06	0.00165	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ANXA1—stomach cancer	1.19e-06	0.00164	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKAB1—stomach cancer	1.18e-06	0.00162	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ANXA1—stomach cancer	1.17e-06	0.0016	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RNF43—stomach cancer	1.16e-06	0.0016	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KISS1—stomach cancer	1.16e-06	0.0016	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	1.16e-06	0.00159	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RNF43—stomach cancer	1.14e-06	0.00156	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KISS1—stomach cancer	1.14e-06	0.00156	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	1.13e-06	0.00155	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ADRB1—stomach cancer	1.13e-06	0.00155	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FST—stomach cancer	1.04e-06	0.00142	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	1.03e-06	0.00142	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	1.01e-06	0.00139	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FST—stomach cancer	1.01e-06	0.00139	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RGS2—stomach cancer	1e-06	0.00137	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GAST—stomach cancer	1e-06	0.00137	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	9.93e-07	0.00136	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GAST—stomach cancer	9.79e-07	0.00134	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RGS2—stomach cancer	9.79e-07	0.00134	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGG—stomach cancer	9.49e-07	0.0013	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	9.36e-07	0.00129	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGG—stomach cancer	9.28e-07	0.00127	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	9.18e-07	0.00126	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	9.13e-07	0.00125	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	8.98e-07	0.00123	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	8.93e-07	0.00123	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RBP4—stomach cancer	8.82e-07	0.00121	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	8.81e-07	0.00121	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RBP4—stomach cancer	8.63e-07	0.00118	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	8.62e-07	0.00118	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	7.58e-07	0.00104	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	7.58e-07	0.00104	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—BMP2—stomach cancer	7.5e-07	0.00103	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—F2R—stomach cancer	7.5e-07	0.00103	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	7.42e-07	0.00102	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	7.42e-07	0.00102	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	7.38e-07	0.00101	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—F2R—stomach cancer	7.33e-07	0.00101	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—BMP2—stomach cancer	7.33e-07	0.00101	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	7.3e-07	0.001	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	7.22e-07	0.000991	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	7.14e-07	0.00098	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	7.07e-07	0.00097	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	7.05e-07	0.000968	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	6.91e-07	0.000949	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	6.9e-07	0.000947	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	6.68e-07	0.000917	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RPS6—stomach cancer	6.52e-07	0.000895	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	6.42e-07	0.000881	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	6.39e-07	0.000878	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	6.38e-07	0.000876	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	6.28e-07	0.000862	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	6.25e-07	0.000858	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	5.99e-07	0.000823	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	5.86e-07	0.000805	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	5.7e-07	0.000783	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	5.67e-07	0.000779	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	5.58e-07	0.000766	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	5.55e-07	0.000762	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	5.53e-07	0.000759	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	5.42e-07	0.000744	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	5.3e-07	0.000728	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	5.15e-07	0.000707	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	5.04e-07	0.000692	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	5.03e-07	0.000691	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	4.98e-07	0.000684	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	4.92e-07	0.000676	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	4.87e-07	0.000669	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FYN—stomach cancer	4.78e-07	0.000656	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FYN—stomach cancer	4.67e-07	0.000642	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	4.52e-07	0.000621	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	4.49e-07	0.000616	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	4.42e-07	0.000607	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	4.39e-07	0.000602	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	4.11e-07	0.000564	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	4.02e-07	0.000552	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	3.98e-07	0.000547	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	3.97e-07	0.000546	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	3.9e-07	0.000535	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	3.89e-07	0.000534	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	3.79e-07	0.00052	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	3.78e-07	0.000518	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	3.71e-07	0.000509	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	3.69e-07	0.000507	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APC—stomach cancer	3.63e-07	0.000498	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APC—stomach cancer	3.55e-07	0.000487	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	3.47e-07	0.000477	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	3.4e-07	0.000467	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	3.37e-07	0.000462	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	3.31e-07	0.000454	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	3.31e-07	0.000454	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	3.3e-07	0.000452	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	3.23e-07	0.000444	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	3.23e-07	0.000444	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	3.16e-07	0.000434	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	3.15e-07	0.000433	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	3.12e-07	0.000429	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	3.09e-07	0.000424	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	3.09e-07	0.000424	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	3.05e-07	0.000419	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	3.04e-07	0.000418	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	3.01e-07	0.000413	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	2.98e-07	0.000409	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	2.95e-07	0.000404	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	2.87e-07	0.000394	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	2.82e-07	0.000387	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	2.81e-07	0.000385	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	2.76e-07	0.000378	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	2.67e-07	0.000367	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	2.65e-07	0.000364	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	2.61e-07	0.000359	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	2.61e-07	0.000358	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	2.6e-07	0.000356	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	2.55e-07	0.00035	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	2.54e-07	0.000349	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	2.49e-07	0.000342	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	2.49e-07	0.000341	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—JUN—stomach cancer	2.48e-07	0.000341	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	2.43e-07	0.000334	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—JUN—stomach cancer	2.43e-07	0.000334	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	2.42e-07	0.000332	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	2.41e-07	0.000331	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	2.36e-07	0.000325	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	2.36e-07	0.000323	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	2.35e-07	0.000323	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	2.3e-07	0.000316	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	2.17e-07	0.000298	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	2.15e-07	0.000295	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	2.12e-07	0.000291	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	2.1e-07	0.000289	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	2.05e-07	0.000282	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	2.01e-07	0.000276	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MYC—stomach cancer	2e-07	0.000274	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	1.95e-07	0.000268	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MYC—stomach cancer	1.95e-07	0.000268	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	1.95e-07	0.000268	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	1.91e-07	0.000262	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	1.91e-07	0.000262	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	1.84e-07	0.000253	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	1.8e-07	0.000248	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	1.69e-07	0.000233	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	1.66e-07	0.000228	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TP53—stomach cancer	1.64e-07	0.000225	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TP53—stomach cancer	1.6e-07	0.00022	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	1.57e-07	0.000215	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	1.53e-07	0.000211	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6—stomach cancer	1.5e-07	0.000206	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6—stomach cancer	1.47e-07	0.000202	CbGpPWpGaD
